ReP USP - Resultado da busca

Artigo de periodico
Trends in cardiometabolic risk factors in the Americas between 1980 and 2014: a pooled analysis of population-based surveys (2020)
Miranda, J. Jaime; Carrillo-larco, Rodrigo M; Ferreccio, Catterina; Hambleton, Ian R; Lotufo, Paulo Andrade ; Nieto-Martinez, Ramfis; Zhou, Bin; Bentham, James; Bixby, Honor; Manitto, Alicia Matijasevich
Source: Lancet global health. Unidade: FM
Subjects: DOENÇAS METABÓLICAS, DOENÇAS CARDIOVASCULARES, FATORES DE RISCO, PREVALÊNCIA, ÍNDICE DE MASSA CORPORAL, OBESIDADE, HIPERTENSÃO, DIABETES MELLITUS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MIRANDA, J. Jaime et al. Trends in cardiometabolic risk factors in the Americas between 1980 and 2014: a pooled analysis of population-based surveys. Lancet global health, v. 8, n. 1, p. E123-E133, 2020Tradução . . Disponível em: http://observatorio.fm.usp.br/handle/OPI/34307. Acesso em: 11 nov. 2024.
APA
Miranda, J. J., Carrillo-larco, R. M., Ferreccio, C., Hambleton, I. R., Lotufo, P. A., Nieto-Martinez, R., et al. (2020). Trends in cardiometabolic risk factors in the Americas between 1980 and 2014: a pooled analysis of population-based surveys. Lancet global health, 8( 1), E123-E133. Recuperado de http://observatorio.fm.usp.br/handle/OPI/34307
NLM
Miranda JJ, Carrillo-larco RM, Ferreccio C, Hambleton IR, Lotufo PA, Nieto-Martinez R, Zhou B, Bentham J, Bixby H, Manitto AM. Trends in cardiometabolic risk factors in the Americas between 1980 and 2014: a pooled analysis of population-based surveys [Internet]. Lancet global health. 2020 ; 8( 1): E123-E133.[citado 2024 nov. 11 ] Available from: http://observatorio.fm.usp.br/handle/OPI/34307
Vancouver
Miranda JJ, Carrillo-larco RM, Ferreccio C, Hambleton IR, Lotufo PA, Nieto-Martinez R, Zhou B, Bentham J, Bixby H, Manitto AM. Trends in cardiometabolic risk factors in the Americas between 1980 and 2014: a pooled analysis of population-based surveys [Internet]. Lancet global health. 2020 ; 8( 1): E123-E133.[citado 2024 nov. 11 ] Available from: http://observatorio.fm.usp.br/handle/OPI/34307
Artigo de periodico
The PARP inhibitor olaparib exerts beneficial effects in mice subjected to cecal ligature and puncture and in cells subjected to oxidative stress without impairing DNA integrity: A potential opportunity' for repurposing a clinically used oncological drug for the experimental therapy of sepsis (2019)
Ahmad, Akbar; Vieira, Juliana de Camargo; Mello, Aline Haas de; Lima, Thais Martins de; Ariga, Suely Kubo; Barbeiro, Denise Frediani; Barbeiro, Hermes Vieira; Szczesny, Bartosz; Toro, Gabor; Druzhyna, Nadiya
Source: Pharmacological research. Unidade: FM
Subjects: TRANSFERASES, CAMUNDONGOS, CHOQUE SÉPTICO, ESTRESSE OXIDATIVO, LIGADURA, PUNÇÕES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AHMAD, Akbar et al. The PARP inhibitor olaparib exerts beneficial effects in mice subjected to cecal ligature and puncture and in cells subjected to oxidative stress without impairing DNA integrity: A potential opportunity' for repurposing a clinically used oncological drug for the experimental therapy of sepsis. Pharmacological research, v. 145, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.phrs.2019.104263. Acesso em: 11 nov. 2024.
APA
Ahmad, A., Vieira, J. de C., Mello, A. H. de, Lima, T. M. de, Ariga, S. K., Barbeiro, D. F., et al. (2019). The PARP inhibitor olaparib exerts beneficial effects in mice subjected to cecal ligature and puncture and in cells subjected to oxidative stress without impairing DNA integrity: A potential opportunity' for repurposing a clinically used oncological drug for the experimental therapy of sepsis. Pharmacological research, 145. doi:10.1016/j.phrs.2019.104263
NLM
Ahmad A, Vieira J de C, Mello AH de, Lima TM de, Ariga SK, Barbeiro DF, Barbeiro HV, Szczesny B, Toro G, Druzhyna N. The PARP inhibitor olaparib exerts beneficial effects in mice subjected to cecal ligature and puncture and in cells subjected to oxidative stress without impairing DNA integrity: A potential opportunity' for repurposing a clinically used oncological drug for the experimental therapy of sepsis [Internet]. Pharmacological research. 2019 ; 145[citado 2024 nov. 11 ] Available from: https://doi.org/10.1016/j.phrs.2019.104263
Vancouver
Ahmad A, Vieira J de C, Mello AH de, Lima TM de, Ariga SK, Barbeiro DF, Barbeiro HV, Szczesny B, Toro G, Druzhyna N. The PARP inhibitor olaparib exerts beneficial effects in mice subjected to cecal ligature and puncture and in cells subjected to oxidative stress without impairing DNA integrity: A potential opportunity' for repurposing a clinically used oncological drug for the experimental therapy of sepsis [Internet]. Pharmacological research. 2019 ; 145[citado 2024 nov. 11 ] Available from: https://doi.org/10.1016/j.phrs.2019.104263
Artigo de periodico
Autosomal-recessive mutations in MESD cause osteogenesis imperfecta (2019)
Moosa, Shahida; Yamamoto, Guilherme L; Garbes, Lutz; Keupp, Katharina; Beleza-Meireles, Ana; Moreno, Carolina Araujo; Valadares, Eugenia Ribeiro; Sousa, Sergio B. de; Maia, Sofia; Kim, Chong Ae
Source: American journal of human genetics. Unidade: FM
Subjects: OSTEOGÊNESE IMPERFEITA, MUTAÇÃO GENÉTICA, PROTEÍNAS MORFOGENÉTICAS ÓSSEAS, TRANSDUÇÃO DE SINAL CELULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MOOSA, Shahida et al. Autosomal-recessive mutations in MESD cause osteogenesis imperfecta. American journal of human genetics, v. 105, n. 4, p. 836-843, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.ajhg.2019.08.008. Acesso em: 11 nov. 2024.
APA
Moosa, S., Yamamoto, G. L., Garbes, L., Keupp, K., Beleza-Meireles, A., Moreno, C. A., et al. (2019). Autosomal-recessive mutations in MESD cause osteogenesis imperfecta. American journal of human genetics, 105( 4), 836-843. doi:10.1016/j.ajhg.2019.08.008
NLM
Moosa S, Yamamoto GL, Garbes L, Keupp K, Beleza-Meireles A, Moreno CA, Valadares ER, Sousa SB de, Maia S, Kim CA. Autosomal-recessive mutations in MESD cause osteogenesis imperfecta [Internet]. American journal of human genetics. 2019 ; 105( 4): 836-843.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1016/j.ajhg.2019.08.008
Vancouver
Moosa S, Yamamoto GL, Garbes L, Keupp K, Beleza-Meireles A, Moreno CA, Valadares ER, Sousa SB de, Maia S, Kim CA. Autosomal-recessive mutations in MESD cause osteogenesis imperfecta [Internet]. American journal of human genetics. 2019 ; 105( 4): 836-843.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1016/j.ajhg.2019.08.008

USP Schools

ReP

Filtros

Authors

Subjects

Funding Agencies